Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"coronary heart disease"

Slides: 1–8 of 8
Add to tray Remove from tray

Background: Coronary Heart Disease

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: ACS | CHD | ST-segment elevation myocardial infarction | STEMI | acute coronary syndrome | coronary heart disease | cost | background
An estimated 80 million American adults (1 in 3) have one or more forms of cardiovascular disease. Among these adults, 38,100,000 are estimated to be age 60 or older, and about 16.8 million adults have ischemic heart disease, also known as coronary heart disease.
Add to tray Remove from tray

Health Impact of Cardiovascular Disease in the United States (1)

Presentation: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Patients With Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Keywords: cardiovascular disease | coronary heart disease | ischemic heart disease | health impact
Add to tray Remove from tray

Background: Disease Burden of Diabetes Mellitus

Presentation: Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness
Keywords: diabetes | complications | microvascular | macrovascular | pregnancy | outcomes
Patient Discussion: Treatment You suggest to this patient that they discuss the possibility of adding an ACEI to his current medications. In order to do this, you review with him a patient guide titled, “ACE Inhibitors” and “ARBs” To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease, from the Effective Health Care Program website at: http://effectivehealthcare.ahrq.gov. You explain to him that the guide is based on a review of multiple studies about specific medications for patients with stable ischemic heart disease.
Add to tray Remove from tray

Patient Discussion: Treatment

Presentation: Management of the Patient with Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Patient Discussion. At this point in the discussion you explain to him that this medication is being given in order to reduce the risk of future cardiac events even further than if he was only taking his usual medication. You counsel the patient to call you immediately if he experiences any of the adverse effects such as swelling of the lips or mouth area, which could indicate the patient has developed angioedema. You give him his own copy of the consumer guide titled, “ACE Inhibitors” and “ARBs” To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease, to take home with him to review and keep these important adverse effects in mind.
Add to tray Remove from tray

Patient Discussion

Presentation: Management of the Patient with Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Patient Discussion. The patient asks about the source of the information that you have given him, and you explain it is a summary of a large analysis done at a university that included many studies on the benefits and harms of adding an ACEI and/or ARB to standard therapies for patients with stable ischemic heart disease and preserved LVSF. This information was summarized in a way that would allow patients to make decisions with their doctors regarding their course of treatment. You counsel him to take this guide (“ACE Inhibitors” and “ARBs” To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease) home to share with his family, refer to it from time to time to remind him why he's taking the drugs, and refer to it for descriptions of the adverse effects. After this discussion, you and your patient determine that the decreased risk of nonfatal heart attack, stroke, and death are worth the risk of possibly getting a cough, high levels of potassium, or suddenly fainting.
Add to tray Remove from tray

Patient Discussion

Presentation: Management of the Patient with Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Adverse Events from ACEIs This patient is sent home with his medications and the consumer summary guide (“ACE Inhibitors” and “ARBs” To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease), which he can continue to refer to in the event of questions. In six weeks, he returns to your office with a dry persistent cough that keeps him up at night. He has been referring to the consumer summary guide and wonders if there are any other drugs he can take to help him.
Add to tray Remove from tray

Adverse Events from ACEIs

Presentation: Management of the Patient with Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Add to tray Remove from tray

Background: Prevalence and Burden of Coronary Artery Disease

Presentation: Noninvasive Technologies for Diagnosing Coronary Artery Disease in Women
Keywords: background | coronary artery disease | CAD | women | heart disease | prevalence | mortality
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364